Sulindac Tablet
Product Images NDC 0591-5660

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sulindac (NDC 0591-5660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 1

Image 1
Chemical structure diagram showing the sulfoxide and sulfone forms of Sulindac, including the sulfide precursor. The image depicts molecular configurations and functional groups relevant to Sulindac's chemical transformations, with molecular weight 356.42 and formula C20H17FO3S indicated.*
FDA Label Image

Image 2

Image 2
Label for Sulindac Tablets, USP 150 mg by Actavis Pharma, Inc., presenting as a drug for further processing. The label includes directions to dispense with a medication guide, states the package contains 100 tablets, and provides storage instructions and manufacturer details. It also features a barcode and serialization coding area.*
FDA Label Image

Image 3

Image 3
Label for Sulindac Tablets USP 200 mg by Actavis Pharma, Inc., marked as a drug for further processing. The label indicates the product contains 100 tablets, with storage instructions and manufacturer details including Watson Pharma Private Limited, India, and Teva Pharmaceuticals, New Jersey. The label includes dispensing guidance and a barcode on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.